Trade Bayer ^BAYGn

Bayer (XTRA:BAYN) Expands Ohio Pharma Capacity, Is It Still 24% Below Fair Value?

Florian Wirtz suffers biggest market value drop in Premier League

Kofane Delays Leverkusen Deal As Premier League Interest Grows

Bayer (XTRA:BAYN) Could Be 24% Undervalued As $2.2b Ohio Drug Hub Takes Shape

Zydus launches in U.S. MSN Labs generic of Bayer's PAH drug

Zydus and MSN Launch First Generic Alternative of Bayer's Adempas in the US, ETPharma

Bayer plans $2.2bn pharmaceutical manufacturing facility in Ohio, US

Bayer Unveils $2.2 Billion Manufacturing Facility in Ohio to Expand Drug Production, ETPharma

Bayer To Invest $2.2 Bln In Ohio Pharma Site, To Create 2,100 Jobs

Bayer To Invest $2.2 Bln In Ohio Pharma Manufacturing Campus

Germany's Bayer to invest $2.2 billion in US pharma site

BAYN: Legal Progress Helps, Execution Risk Still Drives The Case

Bayer to invest $2.2 B in new manufacturing site in US to create highly-skilled jobs

President Trump grants disaster relief for Ohio after August storms

Bayer to build $2.2 billion pharmaceutical plant in Ohio

Bayer to Invest $2.2 Billion in U.S. Pharma Manufacturing Expansion | Morningstar

Three-year real-world outcomes of faricimab in pretreated eyes with treatment-resistant neovascular age-related macular degeneration

South Korea Cell and Gene Therapy Manufacturing Market Forecast to 2035 | 29.56% CAGR Unlocks a USD 7.54 Billion Opportunity in CDMO Capacity and GMP Expansion

Bayer Promotes Christoph Koenen to Chief Medical Officer | Morningstar

Effects of semaglutide on kidney disease in type 2 diabetes: a randomized placebo-controlled trial

Case: Patents/Eligibility (D. Del.)

Bayer Advances Patent Suit Over Moderna, Pfizer Covid Vaccines

Bayer (XTRA:BAYN) Stock Could Be Undervalued Following FDA Priority Review News

Bayer launches MiraSOFT stool softener exclusively at CVS

Werner helicase inhibitor for advanced microsatellite instability solid tumors: a phase 1 trial

Bayer Gains FDA Priority Review For Lynkuet Label Expansion In Breast Cancer-Related Indication

Bayer: FDA Grants Priority Review To Lynkuet For New Indication

Bayer's Alka-Seltzer Collaborates with Alka Yagnik for Unique Advertising Campaign, ETBrandEquity

Use of MRI in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease - MAGNIMS consensus recommendations

Global burden of venous thromboembolism: incidence and outcome estimates of deep-vein thrombosis and pulmonary embolism

Investors pile into Bayer €2bn dual tranche hybrids

Vividion's $2 Billion Sale Price Examined by Top Delaware Court

Bayer (XTRA:BAYN) Could Be 15% Undervalued As FDA Clears KERENDIA For Type 1 Kidney Disease

Bayer field trials put innovation to the test and farmers in the driver's seat

Bayer hives off cancer drug Stivarga to Grünenthal for up to $431 million

EPA let Bayer pick dicamba safeguards, then folded them into a proposed US rule

US environment agency let Bayer pick regulations for destructive weedkiller, documents show

Learn Why The Bull Case For Bayer Stock Could Change Following Kidney Disease Approval

Bayer's Kerendia Wins FDA Approval As First New CKD Treatment For Type 1 Diabetes In 30 Years

Bayer: FDA Approves Kerendia To Treat Chronic Kidney Disease Associated With Type 1 Diabetes

Bayer (XTRA:BAYN) Wins FDA Approval As Fair Value Stays In Focus

Bayer: Genome editing and AI could accelerate the next generation of crop innovation

Apollo Funds Complete Euro3 Billion Capital Solution for Bayer

What to watch on TV today (16 Sept, 2026)

Judge To Begin Consideration Of Bayer's $7.25 Billion Roundup Settlement

Gene and Cell Therapies for CNS Disorders Set for Transformative Growth Through 2036, Driven by Pipeline Innovation, Rising Disease Burden, and Expanding Market Opportunities

Axios Live: Health leaders emphasize AI progress with human oversight

Bayer's Viconic soybean trait aims to give farmers more weed-control flexibility

Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC

Karnataka woos Bayer, Philips, Royal Swinkels for investments

Bayer Roundup $7.25 billion settlement final approval hearing

Bayer faces pivotal test of $7.25 billion Roundup settlement in Missouri court

Bayer Launches Nationwide Science Delivers Tour to Take Science on the Road | Morningstar

Phinomics Appoints Mark Ross as Chief Data Engineering Officer, Guido Mathews as Chief Business Officer

Bayer's Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion

Bayer Secures FDA Accelerated Approval For HYRNUO In HER2-Mutated Non-small Cell Lung Cancer

Radioligand Therapies Market Expected to Witness Significant Growth by 2036, Driven by Rising Cancer Burden, Precision Oncology, and Expansion of Next-generation Radioligand Therapies | DelveInsight | ABNewswire

Bayer Gets FDA Accelerated Approval for Lung Cancer Treatment | Morningstar

Bayer and Neste Close Commercial Agreement to Jointly Scale newgold® Winter Canola for Biofuels Production

MustGrow targets $380B agriculture market with field-proven, mustard-based biologicals

Developer plans transformation for portion of Bayer campus in Creve Coeur

Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial

Commercial Assessment of the Diabetic Nephropathy Market 2026-2036 Featuring Boehringer Ingelheim, Eli Lilly, Bayer, AstraZeneca, UCB Biopharma, Serodus, and Palatin